FK 506 dose in transplantation: from theory to practice.
Faivre
L
L
Pharmacy, Paul Brousse Hospital, Villejuif, France.
Saoudi
S
S
Astier
A
A
Hamadas
C
C
Conort
O
O
Boivin
H
H
Sabatier
B
B
Taburet
A
A
Lecointre
K
K
Bellanger
A
A
Radideau
E
E
Thuillier
A
A
D000293:Adolescent; D000328:Adult; D003920:Diabetes Mellitus / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology; D006785:Hospitals, University; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D016040:Lung Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010297:Paris; D011183:Postoperative Complications; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014181:Transplantation Immunology
D007166:Immunosuppressive Agents; D016559:Tacrolimus